Mrunalini Dandamudi/X
Mar 7, 2026, 15:10
Mrunalini Dandamudi: Perspective on Drug Coated Balloons in Coronary In-Stent Restenosis
Mrunalini Dandamudi, Fellow in AHFTC at Montefiore Einstein medical center, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Perspective on Drug coated balloons in Coronary in-stent Restenosis.
Congratulations team.”
Title: Drug-coated balloons in coronary in-stent restenosis: a systematic review and meta-analysis comparing sirolimus and biolimus with paclitaxel platforms
Authors: Mrunalini Dandamudi, Muhammad Aqib Faizan, Tooba Rehman, Caterina Lecchi, Manoj Ghimire, Jyothik Varun Inampudi, John Cedric Mojica, Salomon Chamay, Juliana Giorgi
Read the Full Article on Cardiovascular Intervention and Therapeutics.
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 5, 2026, 16:28Jon Douglas: Imperial College London Review Maps Key Pathways in Autoimmune Thrombosis
-
Sep 5, 2026, 16:21Kelly Anderson: Bilateral Foot Pain and Purple Toes – Spotting Vascular Complications in Polycythemia Vera
-
Sep 5, 2026, 16:16Hazem Abosheaishaa: Beta-Blocker Selection Matters – Multi-Institutional Cohort Insights on PVT and Survival in Cirrhosis
-
Sep 5, 2026, 16:08Indre Ceponiene: Major Gaps in Secondary Cardiovascular Prevention Across Europe
-
Sep 5, 2026, 16:03W. Alberto Sifuentes Giraldo: Why Obstetric Cases Are Missed Under 2023 ACR/EULAR APS Criteria
-
Sep 5, 2026, 15:58Srikanth Nalla: A Case of Saddle Pulmonary Embolism
-
Sep 5, 2026, 15:55COPD-specific Pulmonary Embolism Diagnostic Strategy – Thrombosis and Haemostasis
-
Sep 5, 2026, 15:41Sam Tsimikas on Lp(a) HORIZON Topline Results – What Missed Endpoints Mean for Cardiovascular Risk
-
Sep 5, 2026, 15:32Stefano Garzon: SELUTION DeNovo HBR – Weren’t HBR Patients Supposed to Bleed More with DES?